APA

Boyd A., Moh R., Maylin S., Abdou Chekaraou M., Mahjoub N., Gabillard D., Anglaret X., Eholié S. P., Delaugerre C., Danel C., Zoulim F. & Lacombe K. (20190906). Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa. : Journal of viral hepatitis.

Chicago

Boyd A, Moh R, Maylin S, Abdou Chekaraou M, Mahjoub N, Gabillard D, Anglaret X, Eholié S P, Delaugerre C, Danel C, Zoulim F and Lacombe K. 20190906. Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa. : Journal of viral hepatitis.

Harvard

Boyd A., Moh R., Maylin S., Abdou Chekaraou M., Mahjoub N., Gabillard D., Anglaret X., Eholié S. P., Delaugerre C., Danel C., Zoulim F. and Lacombe K. (20190906). Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa. : Journal of viral hepatitis.

MLA

Boyd A, Moh R, Maylin S, Abdou Chekaraou M, Mahjoub N, Gabillard D, Anglaret X, Eholié S P, Delaugerre C, Danel C, Zoulim F and Lacombe K. Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa. : Journal of viral hepatitis. 20190906.